ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Cara Therapeutics Inc

Cara Therapeutics Inc (CARA)

0.4636
0.0062
(1.36%)
Closed December 24 3:00PM
0.445
-0.0186
(-4.01%)
After Hours: 3:46PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.4636
Bid
0.44
Ask
0.443
Volume
1,208,384
0.4105 Day's Range 0.4727
0.2257 52 Week Range 1.15
Market Cap
Previous Close
0.4574
Open
0.4574
Last Trade Time
Financial Volume
US$ 534,845
VWAP
0.442612
Average Volume (3m)
1,484,274
Shares Outstanding
54,855,514
Dividend Yield
-
PE Ratio
-0.21
Earnings Per Share (EPS)
-2.16
Revenue
20.97M
Net Profit
-118.51M

About Cara Therapeutics Inc

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Cara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CARA. The last closing price for Cara Therapeutics was US$0.46. Over the last year, Cara Therapeutics shares have traded in a share price range of US$ 0.2257 to US$ 1.15.

Cara Therapeutics currently has 54,855,514 shares outstanding. The market capitalization of Cara Therapeutics is US$25.09 million. Cara Therapeutics has a price to earnings ratio (PE ratio) of -0.21.

CARA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.20982.08955223880.25460.51950.2257116429530.35115053CS
40.15952.19960604070.30460.51950.225734387160.34295087CS
120.152749.11547121260.31090.51950.225714842740.33272623CS
260.183665.57142857140.280.51950.225710136280.33230473CS
52-0.1901-29.08061802050.65371.150.22578428340.46399544CS
156-12.2164-96.343848580412.6813.9650.22577185553.93012635CS
260-16.5564-97.276145710917.0229.64730.22577249288.97796092CS

CARA - Frequently Asked Questions (FAQ)

What is the current Cara Therapeutics share price?
The current share price of Cara Therapeutics is US$ 0.4636
How many Cara Therapeutics shares are in issue?
Cara Therapeutics has 54,855,514 shares in issue
What is the market cap of Cara Therapeutics?
The market capitalisation of Cara Therapeutics is USD 25.09M
What is the 1 year trading range for Cara Therapeutics share price?
Cara Therapeutics has traded in the range of US$ 0.2257 to US$ 1.15 during the past year
What is the PE ratio of Cara Therapeutics?
The price to earnings ratio of Cara Therapeutics is -0.21
What is the cash to sales ratio of Cara Therapeutics?
The cash to sales ratio of Cara Therapeutics is 1.2
What is the reporting currency for Cara Therapeutics?
Cara Therapeutics reports financial results in USD
What is the latest annual turnover for Cara Therapeutics?
The latest annual turnover of Cara Therapeutics is USD 20.97M
What is the latest annual profit for Cara Therapeutics?
The latest annual profit of Cara Therapeutics is USD -118.51M
What is the registered address of Cara Therapeutics?
The registered address for Cara Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Cara Therapeutics website address?
The website address for Cara Therapeutics is www.caratherapeutics.com
Which industry sector does Cara Therapeutics operate in?
Cara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M

CARA Discussion

View Posts
koolmc koolmc 1 day ago
it is called trading you should do it sometimes instead of reneging on bets lool :) one of the best market in years and you are still acting like a grumpy old man sucks to be you
👍️0
TrendTrade2016 TrendTrade2016 5 days ago
LOL SURE...CLASSIC
👍️0
koolmc koolmc 5 days ago
nice action :)
👍️0
glenn1919 glenn1919 5 months ago
CARA..............................................https://stockcharts.com/h-sc/ui?s=CARA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
CARA.....................................................https://stockcharts.com/h-sc/ui?s=CARA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
CARA..............................https://stockcharts.com/h-sc/ui?s=CARA&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 months ago
CARA new 52 week low
👍️0
Monksdream Monksdream 1 year ago
CARA under $2
👍️0
WallStreetMyWay WallStreetMyWay 3 years ago
Yeah, good entry room for upwards momentum?
👍️0
WallStreetMyWay WallStreetMyWay 3 years ago
Moving up saved its nice growing money nows is timing?
👍️0
a surfer a surfer 3 years ago
Got some bounce today.
👍️0
BottomBounce BottomBounce 3 years ago
https://www.benzinga.com/news/earnings/21/11/24060763/you-ask-we-analyze-why-sundial-growers-stock-could-slam-short-sellers $CARA
👍️0
conix conix 3 years ago
CARA chart

👍️0
Jake L Jake L 3 years ago
CARA - Update

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
estreet7883 estreet7883 3 years ago
This chart is looking GREAT!!!
👍️0
Jake L Jake L 3 years ago
CARA - On The Run Again

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Update

👍️0
Jake L Jake L 3 years ago
CARA - Wednesday Rundown, Thursday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Monday Rundown, Tuesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Monday Rundown, Tuesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Major Buy Alert

👍️0
Jake L Jake L 3 years ago
CARA - SHOULD HAVE IN YOUR WATCH LIST

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown

👍️0
Jake L Jake L 3 years ago
CARA - Update Morning Report

👍️0
MikeKato2002 MikeKato2002 3 years ago
Correct! I rode this one back in 2016 betting that some day they would get FDA approval for a marketable product. Now we have that marketable product and a good chunk of money to fund the pipeline for the next product. Meanwhile the stock trades at a historically deep discount to where it was without FDA approval.

I'm back in at $14.50 for the first time since 2016. Free money.

Good Luck!

04/20/2016 08:26:57 Bought 1200 CARA @ 8.98

-10,785.95 9.95 0.00

04/20/2016 08:26:57 Bought 300 CARA @ 8.97

-2,691.00 0.00 0.00

04/20/2016 09:51:48 Bought 500 CARA @ 8.51

-4,264.95 9.95 0.00

04/29/2016 12:04:51 Bought 1000 CARA @ 6.05

-6,059.95 9.95 0.00

11/16/2016 18:23:35 Sold 2500 CARA @ 12.24

30,589.38 9.95 0.67

11/18/2016 20:22:06 Sold 500 CARA @ 12.0202

6,000.02 9.95 0.13
👍️0
Chefboy69 Chefboy69 3 years ago
LONG here, i knew this would recover AFTER the sell on news event. And its up on lower volume LOL. This is a $30-$40 long term stock. IT will take a few months but it will get there.

This is no pump and i don't ever post in here. Just wanted to post and now i am out..see ya

and good luck all
👍️0
Jake L Jake L 3 years ago
CARA - Wednesday Rundown, Thursday Expectations

👍️0
MikeKato2002 MikeKato2002 3 years ago
Item 8.01 Other Information.


As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (“Cara”) received approval of its New Drug Application for KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the “Approval Milestone”). Pursuant to a securities purchase agreement (the “Purchase Agreement”) between Cara and Vifor (International) Ltd. (“Vifor Pharma”), dated October 15, 2020, Cara is eligible to receive $50 million common stock investment at a 20% premium to the 30-day trailing average price of Cara’s common stock ending on the date immediately prior to the achievement of the Approval Milestone. A description of the Purchase Agreement is included in Cara’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on October 20, 2020 and is incorporated herein by reference.



In connection with the achievement of the Approval Milestone on August 23, 2021, Cara will receive from Vifor Pharma a $50.0 million investment in Cara’s common stock at a price of $15.23 per share, equaling 3,282,391 shares of Cara’s common stock (the “Milestone Investment”). The closing of the Milestone Investment will occur within five business days following the expiration of the requisite waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976.



This Current Report on Form 8-K is not an offer to sell or the solicitation of an offer to buy shares of shares of common stock or other securities of Cara.





http://archive.fast-edgar.com/20210831/ABBO422D8C22N2Z2222H2CZZBCASZ2U2D232/tm2126615d1_8k.htm


👍️0
Jake L Jake L 3 years ago
CARA - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Monday Morning Report

👍️0
Jake L Jake L 3 years ago
CARA - Monday's Plays Which will Short Squeeze

👍️0
Jake L Jake L 3 years ago
CARA - 1K To 100K Challenge Update

👍️0
Jake L Jake L 3 years ago
CARA - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Thursday Rundown, Friday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Update 1k to 100k Challenge

👍️0
TheFinalCD TheFinalCD 3 years ago
CARA down amc up


this market is upside down
👍️0
Jake L Jake L 3 years ago
CARA - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
CARA - Don't Panic

👍️0
saigai saigai 3 years ago
well im out as well. and i know a lost a few here...grrrrrr
👍️0
TheFinalCD TheFinalCD 3 years ago
back to 14.60's SMH!!! I sold rest @15+



have to wait to tomorrow to see the net profit/loss

I think I lost a few sheckles on CARA

will check in the am




Sell 3,000 Shares Limit $15.03 Expires on 10/25/2021 1:12 PM 08/24/2021
Sold 500 $15.03 Settles 08/26/2021 1:12 PM 08/24/2021
Sold 100 $15.03 Settles 08/26/2021 1:12 PM 08/24/2021
Sold 100 $15.03 Settles 08/26/2021 1:12 PM 08/24/2021
Canceled 2,300 blank 1:12 PM 08/24/2021
CLOSEDPartial FillCost Basis Method*: View/Edit Order #: 55194959
Resubmit
Sell 2,300 Shares Limit $15.00 Expires on 10/25/2021 1:12 PM 08/24/2021
Sold 2,300 $15.0001 Settles 08/26/2021 1:12 PM 08/24/2021
CLOSEDFilled
👍️0
saigai saigai 3 years ago
only holding 700 got rid of a flip for a few pennies but im not giving up on this ticker yet..i dont want to walk away from this one losing...but i will if i have to
👍️0
TheFinalCD TheFinalCD 3 years ago
sold most around even after adding lower

still have 2500 shares left


#LETS SEE



Sell 4,000 Shares Limit $15.21 Expires on 10/25/2021 12:43 PM 08/24/2021
Sold 2,950 $15.21 Settles 08/26/2021 12:43 PM 08/24/2021
Sold 1,050 $15.21 Settles 08/26/2021 12:43 PM 08/24/2021
CLOSEDFilledCost Basis Method*: View/Edit Order #: 55147402
Sell 4,000 Shares Limit or Better $15.22 Expires on 10/25/2021 12:44 PM 08/24/2021
Sold 500 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 500 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 300 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 200 $15.232 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 1,000 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.23 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 669 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 200 $15.231 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 131 $15.2301 Settles 08/26/2021 12:44 PM 08/24/202
👍️0
TheFinalCD TheFinalCD 3 years ago
I was out @ 17.96, feel like a stooge going back in

giving up profits and going red :/

whats also crazy is todays VWAP is only 15.22

thats low considering 31M volume on 50m os


https://finviz.com/quote.ashx?t=cara


👍️0
TheFinalCD TheFinalCD 3 years ago
SOOOOOOOOOOOOOOOO G00D
👍️0
saigai saigai 3 years ago
what bugs me the most is that this was a trade and i blew it and my long positions are having a good day and this stinking trade teals from those good decisions.. up overall but i hate myself when i kill a good decision with a greedy chase
👍️0
TheFinalCD TheFinalCD 3 years ago
SA article 200% Upside Possible

https://seekingalpha.com/article/4448087-cara-therapeutics-200-percent-upside-possible


WAIT theres more...
https://www.tipranks.com/news/article/cara-therapeutics-could-climb-on-korsuva-drugs-success?utm_source=advfn.com&utm_medium=referral
👍️0

Your Recent History

Delayed Upgrade Clock